Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder
Status:
Terminated
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether increasing the amount (dose) of quetiapine
IR (immediate release formulation) more rapidly than conventional dose increases, improves
the control of symptoms as measured by the Positive and Negative Syndrome Scale (PANSS) - a
psychiatric assessment scale that measures both positive and negative symptoms - in patients
with acute schizophrenia or schizoaffective disorder.